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Background:  Pulmonary hypertension (PH) is common in patients with heart failure and preserved ejection fraction (HFpEF). Prior studies suggest 
a possible pre-capillary component to PH in HFpEF but these studies are limited by lack of invasive hemodynamics. Furthermore, determinants of 
elevated pulmonary vascular resistance (PVR) in HFpEF are unknown. We hypothesized that arterial stiffness, and not pre-capillary PH, is the major 
determinant of elevated PVR and PH in HFpEF.
Methods:  Outpatients (N=174) enrolled in a specialized HFpEF program underwent clinical evaluation, echo, and right heart catheterization. PH 
was defined as invasive mean pulmonary artery (PA) pressure ≥ 25 mmHg. Patients were compared by PVR (< 2.5 WU vs. ≥ 2.5 WU). Multivariable 
logistic regression was used to determine the factors most associated with elevated PVR.
Results:  Clinical characteristics were similar to prior epidemiologic studies. Mean LVEF (61±6%) and pulmonary capillary wedge pressure (PCWP; 
23±7 mmHg) confirmed the diagnosis of HFpEF in study patients. PH was present in 76% and there was little difference (2±3 mmHg) between PA 
diastolic pressure (PADP) and PCWP. Only 17% (30/174) had PVR ≥ 2.5 WU. Compared to PVR < 2.5 WU, those with PVR ≥ 2.5 WU had higher SBP 
(131±20 vs. 123±19 mmHg, p=0.044), increased systemic pulse pressure (60±18 vs. 53±16, p=0.027), and worse renal function (GFR 48±26 vs. 
63±28 ml/min/m2, p=0.008). In patients with PVR > 2.5 WU, total systemic arterial compliance (SV/PP ratio) was lower, and effective systemic 
arterial elastance (0.9*SBP/SV) and systemic vascular resistance were higher (p<0.0001 for all comparisons). PA pulse pressure and PA compliance 
(SV/PA pulse pressure) were also higher in those with elevated PVR (p<0.0001). On multivariable analysis, effective arterial elastance, total arterial 
compliance, and reduced GFR were each independently associated with elevated PVR.
Conclusions:  PH is common in HFpEF. The majority of patients with PH-HFpEF have a minimal PADP-PCWP gradient, and only 17% have elevated 
PVR, which is primarily due to elevated PA pulse pressure and not pre-capillary PH. Reduced GFR and systemic arterial compliance are associated 
with elevated PVR in HFpEF.
